Literature DB >> 10207246

Differential expression of alphav integrins in K1735 melanoma cells.

X Li1, B Chen, S D Blystone, K P McHugh, F P Ross, D M Ramos.   

Abstract

Tumor cell adherence to and migration on the extracellular matrix is an important aspect of cancer progression. This interaction with the extracellular matrix is mediated primarily through the integrin class of cell adhesion molecules. We identified a restricted expression of alphavbeta3 in highly metastatic K1735M2 and of alphavbeta5 in poorly metastatic K1735C23 murine melanoma cells. The highly metastatic cells were ten times more motile on vitronectin and fibronectin and approximately three times more invasive through a reconstituted basement membrane than the poorly metastatic cells. This motility was inhibited by addition of anti-beta3 antibodies. Injection of the alphavbeta3-negative K1735C23 cells into syngeneic mice resulted in the generation of a metastatic variant (K1735C23PM) that neo expressed the alphavbeta3 complex, indicating that expression of alphavbeta3 is required for K1735 melanoma metastasis. Injection of highly metastatic K1735M2 cells in the presence of blocking antibody to beta3 reduced tumor size by approximately 80%. Treatment of the K1735M2 cells with a retroviral antisense beta3 construct significantly reduced their expression of alphavbeta3 and also reduced their motility on extracellular matrix ligands and their invasion through a reconstituted basement membrane. In contrast, when the K1735C23 cells were treated with a construct containing the full-length beta3 cDNA, their motility on extracellular matrix proteins and invasion of a reconstituted basement membrane were significantly increased. These results indicate that alphavbeta3 is required for migration and invasion of K1735 melanoma cells in vitro and primary tumor growth and metastasis in vivo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10207246     DOI: 10.1159/000024494

Source DB:  PubMed          Journal:  Invasion Metastasis        ISSN: 0251-1789


  9 in total

1.  Cross talk between beta(1) and alpha(V) integrins: beta(1) affects beta(3) mRNA stability.

Authors:  S F Retta; G Cassarà; M D'Amato; R Alessandro; M Pellegrino; S Degani; G De Leo; L Silengo; G Tarone
Journal:  Mol Biol Cell       Date:  2001-10       Impact factor: 4.138

2.  Rigidity sensing at the leading edge through alphavbeta3 integrins and RPTPalpha.

Authors:  Guoying Jiang; Angela H Huang; Yunfei Cai; Monica Tanase; Michael P Sheetz
Journal:  Biophys J       Date:  2005-12-09       Impact factor: 4.033

3.  Design, synthesis, and evaluation of near infrared fluorescent multimeric RGD peptides for targeting tumors.

Authors:  Yunpeng Ye; Sharon Bloch; Baogang Xu; Samuel Achilefu
Journal:  J Med Chem       Date:  2006-04-06       Impact factor: 7.446

4.  MicroRNA regulation of integrins.

Authors:  Weiguo Chen; Mark C Harbeck; Wei Zhang; Jeffrey R Jacobson
Journal:  Transl Res       Date:  2013-07-13       Impact factor: 7.012

Review 5.  MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy.

Authors:  Miguel F Segura; Holly S Greenwald; Doug Hanniford; Iman Osman; Eva Hernando
Journal:  Carcinogenesis       Date:  2012-06-12       Impact factor: 4.944

6.  Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway.

Authors:  D Woods; H Cherwinski; E Venetsanakos; A Bhat; S Gysin; M Humbert; P F Bray; V L Saylor; M McMahon
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

7.  B-Raf acts via the ROCKII/LIMK/cofilin pathway to maintain actin stress fibers in fibroblasts.

Authors:  Catrin A Pritchard; Louise Hayes; Leszek Wojnowski; Andreas Zimmer; Richard M Marais; Jim C Norman
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

8.  Protein phosphatase-2A regulates protein tyrosine phosphatase activity in Lewis lung carcinoma tumor variants.

Authors:  Jodi L Jackson; M Rita I Young
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

9.  Positively and negatively modulating cell adhesion to type I collagen via peptide grafting.

Authors:  Gary A Monteiro; Anthony V Fernandes; Harini G Sundararaghavan; David I Shreiber
Journal:  Tissue Eng Part A       Date:  2009-01-27       Impact factor: 3.845

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.